Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.72M Sell
12,520
-2,718
-18% -$383K 0.7% 51
2026
Q2
$2.23M Sell
15,238
-758
-5% -$137K 0.86% 45
2026
Q1
$2.35M Buy
15,996
+37
+0.2% +$6.01K 0.99% 43
2025
Q4
$3.11M Sell
15,959
-967
-6% -$230K 1.2% 26
2025
Q3
$4.76M Sell
16,926
-73
-0.4% -$18.6K 1.74% 18
2025
Q2
$3.72M Sell
16,999
-32,590
-66% -$5.26M 1.43% 22
2025
Q1
$6.93M Sell
49,589
-2,398
-5% -$390K 1.9% 23
2024
Q4
$8.67M Buy
+51,987
New +$9.23M 2.41% 6

Other funds holding ORCL

InvesTrust's ORCL Position: Q3 2026 in Review

InvesTrust reduced its Oracle (ORCL) stake by 18% in Q3 2026, selling an estimated $383K and leaving 12,520 shares worth $1.72M. The position accounts for 0.7% of the portfolio, ranked #51.

InvesTrust first reported a position in ORCL in Q4 2024 and has held it in 8 quarters since. The position peaked at $8.67M in Q4 2024. 1,615 funds tracked by Wall St. Rank hold ORCL as of Q3 2026.

  • InvesTrust held 12,520 shares of Oracle worth $1.72M as of Q3 2026.
  • InvesTrust sold 2,718 Oracle shares in Q3 2026, an estimated $383K.
  • Oracle made up 0.7% of InvesTrust's portfolio in Q3 2026, its #51 holding.
  • InvesTrust first reported a position in Oracle in Q4 2024 and has held it in 8 quarters since.
  • InvesTrust's Oracle position peaked at $8.67M in Q4 2024.
  • 1,615 funds tracked by Wall St. Rank held Oracle as of Q3 2026.

Based on InvesTrust's 13F filing for Q3 2026, filed 14 Oct 2026.